Article Data

  • Views 2310
  • Dowloads 198


Open Access

The value of clinical scores in predicting mortality of adult patients on veno-arterial extracorporeal membrane oxygenation

  • Mohamed Laimoud1,2,*,
  • Rehan Qureshi1

1Adult Cardiac Surgical Intensive Care Unit (CSICU), King Faisal Specialist Hospital & Research Center, 11564 Riyadh, Saudi Arabia

2Critical Care Medicine department, Cairo University, 12613 Cairo, Egypt

DOI: 10.22514/sv.2022.012 Vol.18,Issue 4,July 2022 pp.5-7

Submitted: 15 November 2021 Accepted: 28 December 2021

Published: 08 July 2022

*Corresponding Author(s): Mohamed Laimoud E-mail:;


Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used for refractory cardiogenic shock and is still associated with frequent morbidities and high mortality. Many risk scores have been used to stratify the patients for rapid decision making. The recent studies using the risk scores during VA-ECMO support were reviewed and the conflicting results were addressed. The Survival After VA-ECMO (SAVE), modified SAVE, Sequential Organ Failure Assessment (SOFA), Simplified Acute Physiology score II (SAPS II), REMEMBER, ENCOURAGE scores were used in retrospective studies without validation prospective studies. The risk scores used in evaluation of adult patients with VA-ECMO support for refractory cardiogenic shock help in clinical judgment but should not affect decision making for withdrawal of support.


Extracorporeal membrane oxygenation; Veno-arterial ECMO; SAVE score; modified SAVE score; SOFA score; REMEMBER score; ENCOURAGE score; SAPS II

Cite and Share

Mohamed Laimoud,Rehan Qureshi. The value of clinical scores in predicting mortality of adult patients on veno-arterial extracorporeal membrane oxygenation. Signa Vitae. 2022. 18(4);5-7.


[1] Pellegrino V, Hockings LE, Davies A. Veno-arterial extracorporeal membrane oxygenation for adult cardiovascular failure. Current Opinion in Critical Care. 2014; 20: 484–492.

[2] Lafç G, Budak AB, Yener AÜ, Cicek OF. Use of extracorporeal membrane oxygenation in adults. Heart, Lung and Circulation. 2014; 23: 10–23.

[3] Barge-Caballero E, Almenar-Bonet L, Gonzalez-Vilchez F, Lambert-Rodríguez JL, González-Costello J, Segovia-Cubero J, et al. Clinical outcomes of temporary mechanical circulatory support as a direct bridge to heart transplantation: a nationwide Spanish registry. European Journal of Heart Failure. 2018; 20: 178–186.

[4] Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. European Heart Journal. 2015; 36: 2246–2256.

[5] Laimoud M, Alanazi M, Qureshi R. Hospital outcomes after emergent peripheral veno-arterial extracorporeal membrane oxygenation in adult patients presenting with cardiogenic shock. Signa Vitae. 2021; 17: 103–109.

[6] Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, Léger P, et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Critical Care Medicine. 2008; 36: 1404–1411.

[7] Laimoud M, Alanazi M. The Validity of SOFA score to predict mortality in adult patients with cardiogenic shock on venoarterial extracorporeal membrane oxygenation. Critical Care Research and Practice. 2020; 2020: 3129864.

[8] Lorusso R, Barili F, Mauro MD, Gelsomino S, Parise O, Rycus PT, et al. In-hospital neurologic complications in adult patients undergoing venoar-terial extracorporeal membrane oxygenation. Critical Care Medicine. 2016; 44: e964–e972.

[9] Laimoud M, Ahmed W. Acute neurological complications in adult pa-tients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation support. The Egyptian Heart Journal. 2020; 72: 26.

[10] Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1866 adult patients. The Annals of Thoracic Surgery. 2014; 97: 610–616.

[11] Laimoud M, Saad E, Koussayer S. Acute vascular complications of femoral veno-arterial ECMO: a single-centre retrospective study. The Egyptian Heart Journal. 2021; 73: 15.

[12] Crow S, Fischer AC, Schears RM. Extracorporeal life support: utilization, cost, controversy, and ethics of trying to save lives. Seminars in Cardiothoracic and Vascular Anesthesia. 2009; 13: 183–191.

[13] Chung M, Zhao Y, Strom JB, Shen C, Yeh RW. Extracorporeal Membrane Oxygenation Use in Cardiogenic Shock: impact of age on in-hospital mortality, length of stay, and costs. Critical Care Medicine. 2019; 47: e214–e221.

[14] Chen WC, Huang KY, Yao CW, Wu CF, Liang SJ, Li CH, et al. The modified save score: predicting survival using urgent veno-arterial extracorporeal membrane oxygenation within 24 hours of arrival at the emergency department. Critical Care. 2016; 20: 336.

[15] Amin F, Lombardi J, Alhussein M, Posada JD, Suszko A, Koo M, et al. Predicting survival after VA-ECMO for refractory cardiogenic shock: validating the save score. CJC Open. 2021; 3: 71–81.

[16] Muller G, Flecher E, Lebreton G, Luyt CE, Trouillet JL, Bréchot N, et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Medicine. 2016; 42: 370–378.

[17] Wang L, Yang F, Wang X, Xie H, Fan E, Ogino M, et al. Predicting mortality in patients undergoing VA-ECMO after coronary artery bypass grafting: the remember score. Critical Care. 2019; 23: 11.

[18] Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Medicine. 1996; 22: 707–710.

[19] Akin S, Caliskan K, Soliman O, Muslem R, Guven G, van Thiel RJ, et al. A novel mortality risk score predicting intensive care mortality in cardiogenic shock patients treated with veno-arterial extracorporeal membrane oxygenation. Journal of Critical Care. 2020; 55: 35–41.

[20] Lee HS, Kim HS, Lee SH, Lee SA, Hwang JJ, Park JB, et al. Clinical implications of the initial SAPS II in veno-arterial extracorporeal oxygenation. Journal of Thoracic Disease. 2019; 11: 68–83.

[21] Fisser C, Rincon-Gutierrez LA, Enger TB, Taccone FS, Broman LM, Belliato M, et al. Validation of prognostic scores in extracorporeal life support: a multi-centric retrospective study. Membranes. 2021; 11: 84.

[22] Barbaro RP, Odetola FO, Kidwell KM, Paden ML, Bartlett RH, Davis MM, et al. Association of hospital-level volume of extracorporeal mem-brane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. American Journal of Respiratory and Critical Care Medicine. 2015; 191: 894–901.

[23] Extracorporeal Life Support Organization. Guidelines for ECPR Cases. 2013. Available at: 3.pdf (Accessed: 13 December 2020).

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time